Anika Therapeutics, Inc.

NasdaqGS:ANIK 주식 보고서

시가총액: US$255.3m

Anika Therapeutics 관리

관리 기준 확인 3/4

Anika Therapeutics CEO는 Cheryl Blanchard, Feb2020 에 임명되었습니다 의 임기는 4.75 년입니다. 총 연간 보상은 $ 4.46M, 16.3% 로 구성됩니다. 16.3% 급여 및 83.7% 보너스(회사 주식 및 옵션 포함). 는 $ 3.05M 가치에 해당하는 회사 주식의 1.2% 직접 소유합니다. 3.05M. 경영진과 이사회의 평균 재임 기간은 각각 3 년과 4.2 년입니다.

주요 정보

Cheryl Blanchard

최고 경영자

US$4.5m

총 보상

CEO 급여 비율16.3%
CEO 임기4.8yrs
CEO 소유권1.2%
경영진 평균 재임 기간3yrs
이사회 평균 재임 기간4.2yrs

최근 관리 업데이트

Recent updates

Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 44% Undervaluation?

Jan 30
Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 44% Undervaluation?

Companies Like Anika Therapeutics (NASDAQ:ANIK) Can Afford To Invest In Growth

Aug 03
Companies Like Anika Therapeutics (NASDAQ:ANIK) Can Afford To Invest In Growth

Anika Therapeutics: New Share Price Low May Imply New Upside Opportunity

Mar 11

Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%?

Jun 25
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%?

Anika Therapeutics (ANIK) Presents At UBS Global Healthcare Virtual Conference - Slideshow

May 28

Anika Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

How Much Are Anika Therapeutics, Inc. (NASDAQ:ANIK) Insiders Taking Off The Table?

Mar 16
How Much Are Anika Therapeutics, Inc. (NASDAQ:ANIK) Insiders Taking Off The Table?

Anika Therapeutics (NASDAQ:ANIK) Seems To Use Debt Quite Sensibly

Feb 09
Anika Therapeutics (NASDAQ:ANIK) Seems To Use Debt Quite Sensibly

An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 32% Undervalued

Jan 13
An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 32% Undervalued

If You Had Bought Anika Therapeutics' (NASDAQ:ANIK) Shares A Year Ago You Would Be Down 21%

Dec 18
If You Had Bought Anika Therapeutics' (NASDAQ:ANIK) Shares A Year Ago You Would Be Down 21%

Anika Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 06

CEO 보상 분석

Cheryl Blanchard 의 보수는 Anika Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$98m

Jun 30 2024n/an/a

-US$74m

Mar 31 2024n/an/a

-US$77m

Dec 31 2023US$4mUS$726k

-US$83m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$22m

Mar 31 2023n/an/a

-US$22m

Dec 31 2022US$6mUS$695k

-US$15m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$11m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$4mUS$668k

US$4m

Sep 30 2021n/an/a

-US$6m

Jun 30 2021n/an/a

-US$13m

Mar 31 2021n/an/a

-US$27m

Dec 31 2020US$10mUS$548k

-US$24m

Sep 30 2020n/an/a

-US$4m

Jun 30 2020n/an/a

US$11m

Mar 31 2020n/an/a

US$28m

Dec 31 2019US$187kn/a

US$27m

Sep 30 2019n/an/a

US$31m

Jun 30 2019n/an/a

US$29m

Mar 31 2019n/an/a

US$30m

Dec 31 2018US$167kn/a

US$19m

보상 대 시장: Cheryl 의 총 보상 ($USD 4.46M )은 US 시장( $USD 1.46M ).

보상과 수익: Cheryl 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Cheryl Blanchard (60 yo)

4.8yrs

테뉴어

US$4,459,800

보상

Dr. Cheryl Renee Blanchard, Ph. D. is Director of Elute, Inc. from May 2013. She serves as the President & Chief Executive Officer of Anika Therapeutics, Inc. since April 26, 2020. She serves as Director o...

리더십 팀

이름위치테뉴어보상소유권
Cheryl Blanchard
President4.8yrsUS$4.46m1.2%
$ 3.1m
Anne Nunes
Senior VP & COO3.2yrsUS$1.01m0.092%
$ 234.9k
David Colleran
Executive VP4.7yrsUS$1.55m0.23%
$ 575.1k
Michael Levitz
Executive Officerless than a yearUS$1.65m0.32%
$ 818.4k
Stephen Griffin
Executive VPless than a year데이터 없음데이터 없음
Ian McLeod
VP & Chief Accounting Officerno data데이터 없음데이터 없음
Mark Namaroff
Vice President of Investor Relationsno data데이터 없음데이터 없음
James Chase
Senior Vice President of International Sales & Marketing4.5yrs데이터 없음데이터 없음
Ben Joseph
Vice President of Commercial & Corporate Development2.8yrs데이터 없음데이터 없음
Lisa Funiciello
Vice President of Human Resources2.8yrs데이터 없음데이터 없음

3.0yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: ANIK 의 관리팀은 경험 ( 3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Cheryl Blanchard
President6.3yrsUS$4.46m1.2%
$ 3.1m
William Jellison
Independent Directorless than a year데이터 없음0.018%
$ 47.1k
John Henneman
Independent Chair of the Board5.3yrsUS$249.81k0.20%
$ 521.8k
Susan L. Vogt
Independent Director6.1yrsUS$248.98k0.21%
$ 527.8k
Sheryl Conley
Independent Director3.1yrsUS$242.48k0.14%
$ 347.0k
Glenn Larsen
Independent Director9.8yrsUS$237.48k0.21%
$ 528.5k
Joseph Capper
Independent Directorless than a year데이터 없음데이터 없음
Gary Fischetti
Independent Director1.6yrsUS$571.00k0.089%
$ 228.4k
Stephen Richard
Independent Director4.2yrsUS$248.98k0.19%
$ 486.9k

4.2yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: ANIK 의 이사회는 경험(평균 재직 기간 4.2 년)으로 간주됩니다.